RxDoctor Payments Data

Daniel Joyce, MD

Urology · Nashville, TNNPI 1710333182

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $19,042 of the $25,812 with a category attached, or 73.8%. 13 manufacturers reported payments, led by Telix Pharmaceuticals at 58.5% of the total. 2025 is the largest year on record at $22,344, more than ten times the $256 reported in 2021.

$25,812in general payments, 2019–2025

Across 55 payments — averaging $469.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Telix Pharmaceuticals$15K
  • Ferring Pharmaceuticals Inc.$4K
  • Johnson & Johnson$3K
  • Janssen Global Services, LLC$2K
  • Bayer$432
  • Urogen Pharma, Inc.$366
  • plus $1K from 7 others
$53,434in research payments, 2019–2025

Across 4 payments — averaging $13,359 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Janssen Research & Development, LLC$53K

What the payments were for

  • Consulting fees$19,04274%
  • Travel & lodging$2,92011%
  • Food & beverage$3,85015%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$25,812 in reported general payments places this provider in the 85th percentile of 276 urology providers in Tennessee.

See all urology providers in Tennessee

Medicare billing

Part B allowed, 2024
$126,997
Medicare patients
210
Services billed
511

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tamsulosin Hcl13$153

Paid to pharmacies, not to this prescriber.

Other urology in Nashville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →